Squarepoint Ops LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,192,000
+11.4%
34,600
-46.0%
0.02%
-5.9%
Q2 2020$1,070,000
-7.6%
64,060
+15.9%
0.02%
+70.0%
Q3 2019$1,158,000
+276.0%
55,278
+300.6%
0.01%
+233.3%
Q1 2019$308,000
-54.2%
13,800
-50.9%
0.00%
-62.5%
Q4 2018$672,000
-33.3%
28,088
-23.9%
0.01%
-33.3%
Q3 2018$1,007,000
+24.8%
36,916
+23.1%
0.01%
+9.1%
Q2 2018$807,000
+7.3%
30,000
+50.8%
0.01%
-15.4%
Q4 2017$752,00019,8910.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders